SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (1684)8/13/1999 10:24:00 AM
From: Roudy  Read Replies (1) of 1762
 
I can't disagree with IDEC's management of the company. They took their hits when the going was tough but stayed with their plan. They are now being rewarded for good management and decisions. I'm sure they know what will fit them best. I was a TCLN shareholder long before IDPH. They have been in trials for a very long time. The product may sound good, but something is wrong since they can never get past the trials. The market also says that with the share price. You know the medical end of this much better than I do. I pretty much look for good fundamentals and technicals. I don't follow TCLN much, but I know in the past that they have been at the door of opportunity and have yet been able to open it. Just my 2 cents worth, Don
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext